R. Lord

发表

Differential homocysteine levels in renal transplant patients receiving neoral versus tacrolimus.

C. Darby, G. Morris-Stiff, W. A. Jurewicz, 2001, Transplantation proceedings.

Abdominal wall hernia in autosomal dominant polycystic kidney disease

G. Coles, R. Moore, G. Morris-Stiff, 1997, The British journal of surgery.

Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.

N. Hogg, T. Diamantstein, W. Hancock, 1987, Journal of immunology.

Conversion of renal transplant recipients from cyclosporin to low-dose tacrolimus for refractory rejection

J. Hails, R. Moore, K. Baboolal, 1998 .

Prospective randomised study comparing tacrolimus (Prograf) and cyclosporin (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases

R. Moore, C. Darby, G. Morris-Stiff, 1998, Transplant international : official journal of the European Society for Organ Transplantation.

Conversion of renal transplant recipients from cyclosporin to low‐dose tacrolimus for refractory rejection

J. Hails, R. Moore, K. Baboolal, 1998, Transplant international : official journal of the European Society for Organ Transplantation.

The new Banff classification of renal transplant biopsies: a major impact on the adequacy of the cores taken.

R. Moore, C. Darby, G. Morris-Stiff, 2001, Transplantation proceedings.

Femoral neuropathy in renal transplantation.

I. Junaid, R. Lord, J. Kwan, 1993, Transplantation.

Prospective randomized study comparing FK 506 (Prograft) and cyclosporine A (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases.

R. Moore, C. Darby, G. Morris-Stiff, 1998, Transplantation proceedings.

SYNERGY BETWEEN SUBTHERAPEUTIC DOSES OF CYCLOSPORINE AND IMMUNOLOGIC ENHANCEMENT IN RAT RECIPIENTS OF CARDIAC ALLOGRAFTS1

J. Kupiec-Weglinski, W. Padberg, R. Stefano, 1988, Transplantation.

Ureteric obstruction in renal transplants: the role of percutaneous balloon dilatation.

M. Roddie, N. Farah, G. Williams, 1991, Nephrology, Dialysis and Transplantation.

Conversion of renal transplant recipients from cyclosporin (Neoral) to tacrolimus (Prograf) for haemolytic uraemic syndrome

J. Hails, R. Moore, K. Baboolal, 1998, Transplant International.

Haemolytic uraemic syndrome associated with OKT3

R. Moore, K. Baboolal, G. Morris-Stiff, 1996, Transplant international : official journal of the European Society for Organ Transplantation.

Ureteroureterostomy and pyeloureterostomy without native nephrectomy in renal transplantation.

G. Williams, T. Pepera, R. Lord, 1991, British journal of urology.

Management of inguinal herniae in patients on continuous ambulatory peritoneal dialysis: an audit of current UK practice.

D. Bowrey, G. Morris-Stiff, W. A. Jurewicz, 1998, Postgraduate medical journal.

SYNERGY BETWEEN SUBTHERAPEUTIC DOSES OF CYCLOSPORINE AND IMMUNOBIOLOGICAL MANIPULATIONS IN RAT HEART GRAFT RECIPIENTS1

T. Strom, J. Kupiec-Weglinski, W. Padberg, 1988, Transplantation.

A double-blind, randomized, placebo-controlled study of nifedipine on early renal allograft function.

M. Raftery, F. Marsh, M. Wilkie, 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Preoperative induction with tacrolimus does not have a detrimental effect on primary graft function in adult cadaveric renal transplantation.

R. Moore, G. Morris-Stiff, W. A. Jurewicz, 1998, Transplantation proceedings.

Conversion from cyclosporine to tacrolimus in renal allograft recipients with chronic graft nephropathy: preliminary report.

R. Moore, K. Baboolal, G. Morris-Stiff, 1998, Transplantation proceedings.

Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts.

T. Strom, J. Kupiec-Weglinski, W. Padberg, 1987, Transplantation proceedings.

Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement.

T. Strom, J. Kupiec-Weglinski, J. Williams, 1987, Journal of immunology.

Correlation of macrophage and NK cell numbers with "activation markers" in rat cardiac allografts.

J. Kupiec-Weglinski, W. Padberg, W. Hancock, 1989, Transplantation proceedings.

Abdominal wall hernia in autosomal dominant polycystic kidney disease

G. Coles, R. Moore, G. Morris-Stiff, 1997, The British journal of surgery.

W3/25+ T cells mediate the induction of immunologic unresponsiveness in enhanced rat recipients of cardiac allografts.

J. Kupiec-Weglinski, W. Padberg, N. Tilney, 1987, Journal of immunology.

EBV-genome positive monoclonal B cell cerebral lymphoma in a renal allograft recipient following OKT3 therapy.

M. Raftery, P. Altmann, J. Cunningham, 1992, Nephrology, Dialysis and Transplantation.

Tenckhoff catheters post-renal transplantation: the 'pull' technique?

C. Darby, R. Baboo, I. Quiroga, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.